Use of Gadolinium-Based Contrast Agents in Patients with Severe Renal Impairment. Absence of Risk Versus Caution: A Nephrologist's Perspective

Michael R. Rudnick, Ihab M. Wahba, Amanda K. Leonberg-Yoo
2020 Kidney360  
See related article, "Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution" on pages 561-568.
doi:10.34067/kid.0003022020 pmid:35368601 pmcid:PMC8809313 fatcat:si5wdjsvxfavzkfynt6ouxv2ri